MedPath

Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome

Phase 3
Terminated
Conditions
Hemolytic Uremic Syndrome
Interventions
Drug: Placebo
Registration Number
NCT00004465
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Brief Summary

OBJECTIVES: I. Determine the effect of SYNSORB Pk therapy on mortality and frequency of severe extrarenal complications observed in children with acute stage E. coli-associated hemolytic uremic syndrome.

II. Determine the effect of SYNSORB Pk therapy on the need for the duration of dialysis in these patients.

III. Determine the effect of SYNSORB Pk therapy on the recovery of renal function and resolution of urinary abnormalities in these patients.

Detailed Description

PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, multicenter study. Patients are randomized to receive either SYNSORB Pk or placebo.

Patients receive oral SYNSORB Pk or placebo three times daily for 7 days. Patients are followed on days 7, 14, 28, and 60 after discharge from the hospital.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
145
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboCornmeal placebo
SYNSORB PkSYNSORB PkOral Shiga toxin-binding agent (500 mg/kg/day)
Primary Outcome Measures
NameTimeMethod
Time to dialysis60 days
Time to death or serious extrarenal events60 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (27)

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Ohio State University Children's Hospital

🇺🇸

Columbus, Ohio, United States

Indiana University Cancer Center

🇺🇸

Indianapolis, Indiana, United States

Boston Floating Hospital Infants and Children

🇺🇸

Boston, Massachusetts, United States

New York Medical College

🇺🇸

Valhalla, New York, United States

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

North Shore University Hospital

🇺🇸

Manhasset, New York, United States

Maimonides Medical Center

🇺🇸

Brooklyn, New York, United States

Children's Hospital of Buffalo

🇺🇸

Buffalo, New York, United States

St. Barnabas Medical Center

🇺🇸

Livingston, New Jersey, United States

Jack D. Weiler Hospital of the Albert Einstein College of Medicine

🇺🇸

The Bronx, New York, United States

University of Wisconsin Children's Hospital

🇺🇸

Madison, Wisconsin, United States

Alfred I. Dupont Institute

🇺🇸

Wilmington, Delaware, United States

Medical College of Georgia Hospital and Clinics

🇺🇸

Augusta, Georgia, United States

Children's Hospital at St. Joseph's

🇺🇸

Paterson, New Jersey, United States

Weill Medical College of Cornell University

🇺🇸

New York, New York, United States

Long Island Jewish Medical Center

🇺🇸

New Hyde Park, New York, United States

State University of New York Health Sciences Center - Stony Brook

🇺🇸

Stony Brook, New York, United States

Children's Hospital of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

Children's Hospital of the King's Daughters

🇺🇸

Norfolk, Virginia, United States

West Virginia University Hospitals

🇺🇸

Morgantown, West Virginia, United States

University of Alberta

🇨🇦

Edmonton, Alberta, Canada

Robert Wood Johnson Medical School

🇺🇸

New Brunswick, New Jersey, United States

Emory University School of Medicine

🇺🇸

Atlanta, Georgia, United States

Children's Hospital of Denver

🇺🇸

Denver, Colorado, United States

Bowman Gray School of Medicine

🇺🇸

Winston-Salem, North Carolina, United States

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath